Development and validation of nomograms to predict survival in patients with high-grade serous ovarian cancer

被引：0
|
作者：
Peng, X. [1 ]
Liu, J. [2 ]
机构：
[1] Linxiang City Peoples Hosp Hunan Prov, Dept Obstet & Gynecol, Linxiang, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Vasc & Endovasc Surg, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1969
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
791P
引用
收藏
页码：S531 / S531
页数：1
相关论文
共 50 条
  • [1] Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer
    Dai, Danian
    Liu, Lili
    Huang, He
    Chen, Shangqiu
    Chen, Bo
    Cao, Junya
    Luo, Xiaolin
    Wang, Feng
    Luo, Rongzhen
    Liu, Jihong
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] Development and Validation of Nomograms to Predict Overall Survival Outcomes in Serous Ovarian Cancer Patients with Satisfactory Cytoreductive Surgery and Chemotherapy
    Liu, Yuan-Yuan
    Zhao, Ren-Feng
    Liu, Chao
    Zhou, Jie
    Yang, Liu
    Li, Li
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 123 - 131
  • [3] Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma
    Yuan, Dandan
    Zhu, Hong
    Wang, Ting
    Zhang, Yang
    Zheng, Xin
    Qu, Yanjun
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [4] Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma
    Dandan Yuan
    Hong Zhu
    Ting Wang
    Yang Zhang
    Xin Zheng
    Yanjun Qu
    [J]. European Journal of Medical Research, 28
  • [5] Development and validation of an ultrasound‑based radiomics nomogram to predict lymph node status in patients with high-grade serous ovarian cancer: a retrospective analysis
    Yue Qi
    Jinchi Liu
    Xinyue Wang
    Yuqing Zhang
    Zhixun Li
    Xinyu Qi
    Ying Huang
    [J]. Journal of Ovarian Research, 17
  • [6] Validation of the MAL gene as a predictor of survival in advanced-stage high-grade serous ovarian cancer
    Barnett, J. C.
    Iverson, E.
    Dressman, H.
    Whitaker, R.
    Murphy, S. K.
    Lancaster, J.
    Berchuck, A.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S123 - S124
  • [7] Disparities in treatment modalities and survival among older patients with high-grade serous ovarian cancer
    Yan Cai
    Tong Shu
    Hong Zheng
    [J]. BMC Women's Health, 24
  • [8] Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients
    Clarke, Christina L.
    Kushi, Lawrence H.
    Chubak, Jessica
    Pawloski, Pamala A.
    Bulkley, Joanna E.
    Epstein, Mara M.
    Burnett-Hartman, Andrea N.
    Powell, Bethan
    Pearce, Celeste L.
    Feigelson, Heather Spencer
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (05) : 996 - 999
  • [9] Disparities in treatment modalities and survival among older patients with high-grade serous ovarian cancer
    Cai, Yan
    Shu, Tong
    Zheng, Hong
    [J]. BMC WOMENS HEALTH, 2024, 24 (01)
  • [10] Overexpression of stromal biglycan correlates with improved survival in patients with high-grade serous ovarian cancer
    Carroll, A.
    Thompson, M. S.
    Co, C.
    Zaid, T. M.
    Wong, K. K.
    Yeung, T. L.
    Schmandt, R.
    Birrer, M. J.
    Mok, S. C.
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 438 - 438
12345